Kinase Mutations as Predictive Biomarkers in Hematolymphoid Malignancies
Journal Title: Journal of Hematology & Thrombosis - Year 2015, Vol 1, Issue 1
Abstract
Targeted therapeutics against kinases has been employed in the clinic for over a decade. Their use of ten times requires concomitant molecular diagnostics evaluating the mutational status of the targeted kinases. While kinase mutations function as diagnostic and prognostic biomarkers in hematolymphoid malignancies, in this review, we focus on kinase mutations with predictive utility and their relevance to molecular diagnostics.
Authors and Affiliations
Benedict Yan
Keywords
Related Articles
- EP ID EP246384
- DOI 10.13188/2380-6842.1000001
- Views 154
- Downloads 0
Accidental and Surreptitious Intake of Oral Anticoagulants Including Older and Newer Agents - A Diagnostic Dilemma
The newer oral anticoagulants including dabigatran, rivaraxoban, apixaban and edoxaban are replacing warfarin in the management of atrial fibrillation and venous thromboembolism. Accidental and surreptitious overdose of...
Could Denosumab Support Bone Integrity in Sickle Cell Disease
Sickle cell anaemia is a congenital disease characterized by painful vaso-occlusive crises. It is associated with vitamin D deficiency, osteoporosis and recurrent attacks of micro-infarctions lead to bone osteonecrosis....
Effects of Heparin Therapy on Hexagonal Lipid Neutralization Test
In this retrospective study; we evaluate the effects of heparin therapy on hexagonal lipid neutralization test. We identified 8000 patients in our hospital system that had been evaluated for lupus anticoagulants. Among t...
The Promise and Challenges of Personalized Medicine in Hematologic Malignancies
Personalized medicine is a rapidly emerging medical model that proposes individually customized healthcare to potentially increase the quality of clinical care and reduce health care costs. The key to the success of pers...
Pregnancy Complicated Cushing Syndrome Secondary to Adrenal Adenoma
We report a case of Cushing syndrome secondary to adrenal adenoma and the fetus showing nonreactive fetal heart rate pattern on non-stress test some days with general movements (GMs) negative. The tumor was confirmed at...